RPL17 (Ribosomal protein L17, MGC117162, rpL23, gene encoding putative NFkB activating protein) (Control Peptide)

General information
 

Name:
RPL17 (Ribosomal protein L17, MGC117162, rpL23, gene encoding putative NFkB activating protein) (Control Peptide)
Size:
0,1 mg
Catalog no:
MBS659695
Price:
492 EUR
 

Additional extra details
 

  • Other size

    please contact us to order other different size

    Tissue

    control

    Description

    Isotype or positive controls by peptides, antibodies and deactivated samples.cDNA genes are a locus (or region) of DNA for functional transcript RNA or protein. An ELISA is used to detect the expressed protein in biological fluids, serum, saliva.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

  • Gene

    NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA, cytokine production and cell survival. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection (κ light chains are critical components of immunoglobulins). Incorrect regulation of NF-κB has been linked to cancer, inflammatory and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory